Literature DB >> 11919493

Causes and empirical treatment of fever in HIV-infected adult outpatients, Abidjan, Côte d'Ivoire.

Xavier Anglaret1, Nicole Dakoury-Dogbo, Dominique Bonard, Siaka Touré, Patrice Combe, Timothée Ouassa, Hervé Menan, Thérèse N'Dri-Yoman, François Dabis, Roger Salamon.   

Abstract

OBJECTIVES: In Abidjan, HIV prevalence has been estimated at 20% in outpatients attending community clinics. Documenting causes of fever in HIV-infected adult outpatients may help to improve care in these centres with limited facilities.
DESIGN: Prospective study.
METHODS: We describe all diagnoses and treatments made during febrile episodes in HIV-infected adults participating in the ANRS 059 trial and followed up in a dedicated outpatient centre.
RESULTS: Causes of fever could be identified in half of the 269 febrile episodes. Bacterial diseases were the leading identified cause of fever in all CD4 cell count strata (53, 56 and 43% of identified causes in episodes with CD4 count < 200 x 106/l, 200-499 x 106/l, and >or= 500 x 106/l, respectively), followed by malaria (5, 22, and 38%, respectively). Among febrile bacterial diseases, respiratory tract infections and enteritis accounted for 62% of organ involvement, and Streptococcus pneumoniae and non-typhi Salmonella represented 69% of isolated bacterial strains. In these bacterial episodes, an early empirical antibacterial treatment was associated with shorter duration of hospitalization and fever. In the 19 episodes leading to death (7%), the two leading diagnoses were atypical mycobacteriosis (26%) and acute unexplained fever (21%). Death was associated with the absence of antimalarial treatment in the group of acute unexplained fevers.
CONCLUSIONS: African HIV treatment guidelines should take into account the predominant role of bacterial infections and malaria in HIV-infected adult outpatients. Reports from other African settings would be useful to compare experiences in algorithms of empirical early antibacterial and antimalarial treatments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11919493     DOI: 10.1097/00002030-200204120-00011

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  13 in total

1.  Evaluation of 17 medicinal plants from Northern Côte d'Ivoire for their in vitro activity against Streptococcus pneumoniae.

Authors:  W Mamidou Koné; K Kamanzi Atindehou; A Kacou-N'douba; M Dosso
Journal:  Afr J Tradit Complement Altern Med       Date:  2006-08-28

2.  Management of fever in ambulatory HIV-infected adults in resource-limited settings: prospective observational evaluation of a new Mozambican guideline.

Authors:  Paula E Brentlinger; Wilson P Silva; Manuel Buene; Luis Morais; Emilio Valverde; Sten H Vermund; Troy D Moon
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

3.  Progression to WHO criteria for antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Côte d'Ivoire.

Authors:  Albert Minga; Christine Danel; Yao Abo; Lambert Dohoun; Dominique Bonard; Ali Coulibaly; Julien Duvignac; François Dabis; Roger Salamon; Xavier Anglaret
Journal:  Bull World Health Organ       Date:  2007-02       Impact factor: 9.408

4.  Lack of indinavir-associated nephrological complications in HIV-infected adults (predominantly women) with high indinavir plasma concentration in Abidjan, Côte d'Ivoire.

Authors:  Christine Danel; Raoul Moh; Gilles Peytavin; Amani Anzian; Albert Minga; Olivier Ba Gomis; Boga Seri; Gustave Nzunettu; Delphine Gabillard; Roger Salamon; Emmanuel Bissagnene; Xavier Anglaret
Journal:  AIDS Res Hum Retroviruses       Date:  2007-01       Impact factor: 2.205

5.  Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire: impact of alternative methods of CD4 count modelling.

Authors:  Sylvie Deuffic-Burban; Elena Losina; Bingxia Wang; Delphine Gabillard; Eugène Messou; Nomita Divi; Kenneth A Freedberg; Xavier Anglaret; Yazdan Yazdanpanah
Journal:  Eur J Epidemiol       Date:  2007-09-08       Impact factor: 8.082

6.  Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa.

Authors:  Catherine Seyler; Christiane Adjé-Touré; Eugène Messou; Nicole Dakoury-Dogbo; François Rouet; Delphine Gabillard; Monica Nolan; Siaka Toure; Xavier Anglaret
Journal:  AIDS       Date:  2007-05-31       Impact factor: 4.177

7.  Defining disease heterogeneity to guide the empirical treatment of febrile illness in resource poor settings.

Authors:  Lisa J White; Paul N Newton; Richard J Maude; Wirichada Pan-ngum; Jessica R Fried; Mayfong Mayxay; Rapeephan R Maude; Nicholas P J Day
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

8.  Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era.

Authors:  Charlotte Lewden; Youssoufou J Drabo; Djimon M Zannou; Moussa Y Maiga; Daouda K Minta; Papa S Sow; Jocelyn Akakpo; François Dabis; Serge P Eholié
Journal:  J Int AIDS Soc       Date:  2014-04-07       Impact factor: 5.396

9.  Causes of fever in Tanzanian adults attending outpatient clinics: a prospective cohort study.

Authors:  N Boillat-Blanco; Z Mbarack; J Samaka; T Mlaganile; T Kazimoto; A Mamin; B Genton; L Kaiser; V D'Acremont
Journal:  Clin Microbiol Infect       Date:  2020-09-04       Impact factor: 8.067

10.  Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008.

Authors:  Yao Abo; Albert Minga; Hervé Menan; Christine Danel; Timothée Ouassa; Lambert Dohoun; Germain Bomisso; Anthony Tanoh; Eugène Messou; Serge Eholié; Charlotte Lewden; Xavier Anglaret
Journal:  BMC Infect Dis       Date:  2013-12-27       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.